Example: stock market
CLINICAL GUIDELINES: 4 ANTIRETROVIRAL THERAPY
72 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection 4.1 Preparing people living with HIV for ART Before people start antiretroviral therapy (ART), health-care providers should initiate a detailed discussion about the willingness and readiness of patients to initiate ART, the
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
THE SUPPLY CHAIN MANAGER’S HANDBOOK
supplychainhandbook.jsi.comART Antiretroviral therapy ARV Antiretroviral CBA Cost-benefit analysis CEA Cost-effectiveness analysis cGMP Current Good Manufacturing Practice CHW Community health worker CMS Central Medical Stores COGS Cost of goods sold COO Certificate of origin CPR Contraceptive prevalence rate
Annex 1. Example of the semi‐structured interview guide
www.ncbi.nlm.nih.govOpioid substitution therapy . ... 4. HIV care and antiretroviral therapy for IDU . 5. Prevention and treatment of STI . 6. Condom programme . 7. Outreach; information, education and communication for IDUs and their sexual partners . ... For ART treatment initiation and regimen, it is important to assess co-infection. ...
HIV update : 2021
aetc.medicine.ufl.edu2. Initiation of antiretroviral therapy (ART) at time of diagnosis and/or at the time of returning to care after a gap in services Eligibility for Test and Treat: Newly diagnosed HIV patients defined as: Acute Infection: antibody (-)/RNA (+) Recent Infection: antibody (+) with last documented antibody (-) within prior 6 months
HIV/AIDS Health Profile: Sub-Saharan Africa
pdf.usaid.govScaling Up Antiretroviral Therapy. ART coverage in sub-Saharan Africa has scaled up significantly over the past decade. From 2009 to 2010, ART coverage increased more in sub-Saharan Africa than in any other region. During that time, the number of people receiving ART in sub-Saharan Africa grew by approximately 30 percent